MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

NCT06097728 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

825

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable Pleural Mesothelioma

Interventions

DRUG: Volrustomig
DRUG: Pemetrexed
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Nivolumab
DRUG: Ipilimumab

Sponsor

AstraZeneca